Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed

The Food and Drug Administration (FDA) announces its intention to accept and consider a single source application for award of a Cooperative Agreement to the World Health Organization (WHO) in support of collaboration in regulatory systems strengthening, development of norms and standards, and innovative

research to advance global access to safe and effective biological products that meet international standards.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $10,000,000


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement of RFA-FD-21-031 on NIH Guide for Grants and Contracts

Additional Information of Eligibility:
The World Health Organization (WHO)

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-031.html

Contact:


Agency Email Description:
gordana.zuber@fda.hhs.gov

Agency Email:


Date Posted:
2021-04-12

Application Due Date:


Archive Date:
2021-08-12


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


National Wetland Program Development Grants and Five-Star Restoration Training Grant | James Madison Memorial Fellowship Program | Providing Water to At-Risk Natural Desert Terminal Lakes | Upper Colorado and San Juan River Basins Endangered Fish Recovery Programs | People s Garden Grant Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders